Claris Lifesciences has informed about the exit offer public announcement to the remaining public shareholders (Residual Public Shareholders) of the Company made by Athanas Enterprise Private Limited (AEPL or the Promoter) and Claris Holdings Private Limited (CHPL) (collectively referred to as Acquirers) for the acquisition of 22,88,697 fully paid up Equity Shares (representing 4.19% of the paid up share capital of the Company) held by the Residual Public Shareholders of the Company, pursuant to Regulation 21 of the Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009, as amended from time to time (the Delisting Regulations).
The above information is a part of company’s filings submitted to BSE.
